Compare WLTH & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WLTH | BHVN |
|---|---|---|
| Founded | 2008 | 2013 |
| Country | United States | United States |
| Employees | 391 | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.7B |
| IPO Year | N/A | 2022 |
| Metric | WLTH | BHVN |
|---|---|---|
| Price | $8.44 | $13.55 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 14 |
| Target Price | $12.86 | ★ $29.08 |
| AVG Volume (30 Days) | 2.1M | ★ 3.2M |
| Earning Date | 05-18-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 26.08 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $10.58 | N/A |
| Revenue Next Year | $23.43 | N/A |
| P/E Ratio | $10.57 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.20 | $7.48 |
| 52 Week High | $14.12 | $18.57 |
| Indicator | WLTH | BHVN |
|---|---|---|
| Relative Strength Index (RSI) | 28.40 | 70.40 |
| Support Level | $8.29 | $13.41 |
| Resistance Level | $9.32 | $15.71 |
| Average True Range (ATR) | 0.62 | 0.91 |
| MACD | -0.26 | 0.26 |
| Stochastic Oscillator | 8.61 | 84.29 |
Wealthfront Corp is a product-driven technology company that built a financial solutions platform for digital natives. The platform is designed to address the needs of the wealth builders within these generations. Its business model is designed to optimize for clients' success. The focus on delivering fully automated services results in being one of the lowest cost producers in each category in which participate. The group generates revenue from cash management and investment advisory products. Cash management revenue is earned from fees received for the delivery of cash management services, including the cash sweep program.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.